Evidence mapPaperPMID 34057705Full record

Trial reportEating and weight disorders : EWD2022

Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial.

Sahar Cheshmeh, Maysa Ghayyem, Firoozeh Khamooshi, Neda Heidarzadeh-Esfahani, Negin Rahmani, Niloofar Hojati, Elaheh Mosaieby, Shima Moradi, Yahya Pasdar

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Eating and weight disorders : EWD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Antioxidant Activity in Extracts fromMolecules (Basel, Switzerland) · 2023
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sahar CheshmehStudent Research Committee, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Maysa GhayyemResident of Internal Medicine, School of Medicine, Tehran Azad University of Medical Sciences, Tehran, Iran.
Firoozeh KhamooshiStudent Research Committee, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Neda Heidarzadeh-EsfahaniStudent Research Committee, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Negin RahmaniJulius Maximillian University of Wuerzburg, Wuerzburg, Germany.
Niloofar HojatiStudent Research Committee, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Elaheh MosaiebyDepartment of Molecular Biology Sciences, Mazandaran University, Mazandaran, Iran.
Shima MoradiDepartment of Nutritional Sciences, Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Shima.moradi@kums.ac.ir.ORCID http://orcid.org/0000-0002-6507-7928
Yahya PasdarResident of Internal Medicine, School of Medicine, Tehran Azad University of Medical Sciences, Tehran, Iran.
Kermanshah University of Medical Sciences · IRIslamic Azad University Medical Branch of Tehran · IRUniversity of Mazandaran · IRUniversity of Würzburg · DE

Funding

Deputy for Research and Technology, Kermanshah University of Medical Sciences 990412
6 · The paper itself

Abstract

purposePolycystic ovary syndrome (PCOS) is an endocrine disorder and a common cause of infertility among women that is associated with low-grade inflammation. Therefore, the current randomized, double-blind, placebo-controlled clinical trial was conducted to assess the effects of green cardamom supplementation on the serum level of inflammatory markers and their gene expression among obese women with PCOS.

methodsWe included 194 obese women with PCOS and administered low-calorie diet to all of them. These subjects were randomly divided into two groups including the intervention group with 3 g/day green cardamom (n = 99) and the placebo group (n = 95). Anthropometric indices, androgen hormones, and inflammatory factors [tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and C-reactive protein (CRP)] were assessed before and after the 4-month intervention. TNF-α, IL-6, and CRP gene expression levels were measured using reverse transcription-polymerase chain reaction (RT-PCR) method.

resultsAnthropometric indices were improved in both studied groups (P < 0.001). Among androgen hormones, luteinizing hormone, androstenedione, and dehydroepiandrosterone were significantly decreased (P < 0.001), and follicle-stimulating hormone was significantly increased (P < 0.001) in the green cardamom group. Our findings showed that TNF-α, IL-6, and CRP serum levels were significantly decreased after the intervention with green cardamom plus low-calorie diet (P < 0.001). In addition, the expression levels of TNF-α and CRP genes were significantly decreased in the intervention group (P < 0.001).

conclusionsThe present study supports the beneficial anti-inflammatory effect of green cardamom on the inflammatory state in PCOS women. LEVEL OF EVIDENCE: Level I: randomized clinical trial. Trial registration This trial was registered with the Iranian Clinical Trials Registry (registration number: IRCT20200608047697N1). 1 August, 2020; https://www.irct.ir/trial/48748 .

Indexed as

ElettariaPolycystic Ovary SyndromeCaloric RestrictionDietary SupplementsDouble-Blind MethodFemaleHumansIranObesityC-reactive proteinGene expressionInterleukin 6Polycystic ovary syndromeRT-PCRTumor necrosis factor-α

Identifiers

PMID34057705
PMCPMC8166375
OpenAlexW3165045241

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.